Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Chronic Inflammatory Demyelinating Polyneuropathy Manifesting as Neuropathy With Liability to Pressure Palsies: A Case Report.
Pathological correlates of magnetic resonance imaging texture heterogeneity in multiple sclerosis.
Responsiveness to reduced dosage of rituximab in Chinese patients with neuromyelitis optica.
Myelin loss and axonal ion channel adaptations associated with gray matter neuronal hyperexcitability.
Six-year follow-up of a case series with non-communicating syringomyelia in multiple sclerosis.
ApoE-Deficient Promotes Blood-Brain Barrier Disruption in Experimental Autoimmune Encephalomyelitis via Alteration of MMP-9.
IL-17-Producing Vγ4+ γδ T Cells Require Sphingosine 1-Phosphate Receptor 1 for Their Egress from the Lymph Nodes under Homeostatic and Inflammatory Conditions.
[Mitoxantrone role in treatment of primary progressive multiple sclerosis].
NLRP3 inflammasome is associated with the response to IFN-β in patients with multiple sclerosis.
Recent achievements in stem cell-mediated myelin repair.
Decreased circulating miRNA levels in patients with primary progressive multiple sclerosis.
Transient hyperCKemia in the setting of neuromyelitis optica (NMO).
Dynamics of oligodendrocyte generation and myelination in the human brain.
Multiple sclerosis severity and concern about falling: Physical, cognitive and psychological mediating factors.
Modeling the Relationship among Gray Matter Atrophy, Abnormalities in Connecting White Matter, and Cognitive Performance in Early Multiple Sclerosis.
Correlation between spasticity and quality of life in patients with multiple sclerosis: the CANDLE study.
Deficits in memory and visuospatial learning correlate with regional hippocampal atrophy in MS.
Social participation in patients with multiple sclerosis: correlations between disability and economic burden.
Isolation of bacterial plasmid-related replication-associated circular DNA from a serum sample of a multiple sclerosis patient.
Longitudinally Extensive Transverse Myelitis With and Without Aquaporin 4 Antibodies.
Switching and escalating therapy in long-lasting multiple sclerosis: not always necessary.
Ethical considerations when counseling patients about stem cell tourism.
Development of a nanomaterial bio-screening platform for neurological applications.
[Multiple sclerosis, neuromyelitis optica and spasticity: control of specific symptoms and quality of life].
NMDA receptor antibodies associated with distinct white matter syndromes.
Pages
« first
‹ previous
…
351
352
353
354
355
356
357
358
359
…
next ›
last »